Stopped: Study has been withdrawn per decision of Sponsor.
The goal of this clinical trial is to assess basic feasibility, safety, and performance of an EUS access device in patients with malignant biliary obstruction who are indicated to receive EUS-guided hepaticogastrostomy for biliary drainage. The main questions it aims to answer are: * Can the device be used to gain and maintain access to target anatomy? * Does the device have a clinically acceptable safety profile? * How does the device perform overall? All patients will undergo a hepaticogastrostomy procedure and be followed for 7 days post-procedure.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Technical Success
Timeframe: Day 0 Study Procedure
Safety
Timeframe: Day 0 Study Procedure through Day 7 Post-Study Procedure
Device Performance
Timeframe: Day 0 Study Procedure